76 related articles for article (PubMed ID: 27531883)
1. Should severe epithelial dysplasia be treated?
Zhang L; Lubpairee T; Laronde DM; Rosin MP
Oral Oncol; 2016 Sep; 60():125-9. PubMed ID: 27531883
[TBL] [Abstract][Full Text] [Related]
2. Individualized five-year risk assessment for oral premalignant lesion progression to cancer.
Hwang JT; Gu YR; Shen M; Ralhan R; Walfish PG; Pritzker KP; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Mar; 123(3):374-381. PubMed ID: 28110942
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic.
Ho MW; Field EA; Field JK; Risk JM; Rajlawat BP; Rogers SN; Steele JC; Triantafyllou A; Woolgar JA; Lowe D; Shaw RJ
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):594-9. PubMed ID: 23601832
[TBL] [Abstract][Full Text] [Related]
4. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
6. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.
Rosin MP; Lam WL; Poh C; Le ND; Li RJ; Zeng T; Priddy R; Zhang L
Cancer Res; 2002 Nov; 62(22):6447-50. PubMed ID: 12438233
[TBL] [Abstract][Full Text] [Related]
7. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
8. [Premalignant lesions of the oral mucosa. Prognosis, treatment and follow-up].
Merkx MA; ter Hoeven J; de Wilde PC
Ned Tijdschr Tandheelkd; 2005 Feb; 112(2):51-5. PubMed ID: 15747998
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence Visualization-Guided Surgery for Early-Stage Oral Cancer.
Poh CF; Anderson DW; Durham JS; Chen J; Berean KW; MacAulay CE; Rosin MP
JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):209-16. PubMed ID: 26769431
[TBL] [Abstract][Full Text] [Related]
10. Recurrence patterns and management of oral cavity premalignant lesions.
Arnaoutakis D; Bishop J; Westra W; Califano JA
Oral Oncol; 2013 Aug; 49(8):814-7. PubMed ID: 23692699
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of the utilization of vital Lugol's iodine staining in detection and diagnosis of oral cancer and dysplasia.
Elimairi I; Altay MA; Abdoun O; Elimairi A; Tozoglu S; Baur DA; Quereshy F
Clin Oral Investig; 2017 Mar; 21(2):589-595. PubMed ID: 27491775
[TBL] [Abstract][Full Text] [Related]
12. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma of the buccal mucosa: one institution's experience with 119 previously untreated patients.
Diaz EM; Holsinger FC; Zuniga ER; Roberts DB; Sorensen DM
Head Neck; 2003 Apr; 25(4):267-73. PubMed ID: 12658730
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of iodine staining for diagnosis of carcinoma in situ in the floor of mouth, and decision of adequate surgical margin.
Watanabe A; Taniguchi M; Tsujie H; Hosokawa M; Fujita M; Sasaki S
Auris Nasus Larynx; 2012 Apr; 39(2):193-7. PubMed ID: 21885222
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: relationship with cell cycle regulators.
Ralhan R; Chakravarti N; Kaur J; Sharma C; Kumar A; Mathur M; Bahadur S; Shukla NK; Deo SV
Int J Cancer; 2006 Mar; 118(5):1077-89. PubMed ID: 16161051
[TBL] [Abstract][Full Text] [Related]
16. Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions.
Chainani-Wu N; Madden E; Cox D; Sroussi H; Epstein J; Silverman S
Oral Dis; 2015 Oct; 21(7):879-85. PubMed ID: 26173924
[TBL] [Abstract][Full Text] [Related]
17. Biopsy and histopathologic diagnosis of oral premalignant and malignant lesions.
Poh CF; Ng S; Berean KW; Williams PM; Rosin MP; Zhang L
J Can Dent Assoc; 2008 Apr; 74(3):283-8. PubMed ID: 18387269
[TBL] [Abstract][Full Text] [Related]
18. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
[TBL] [Abstract][Full Text] [Related]
19. Pathological features of betel quid-related oral epithelial lesions in taiwan with special emphasis on the tumor progression and human papillomavirus association.
Chang KC; Su IJ; Tsai ST; Shieh DB; Jin YT
Oncology; 2002; 63(4):362-9. PubMed ID: 12417791
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
